This inventor holds 1 USPTO granted patent. Top assignee: Prolynx LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John A. Hangasky III: Inventor of Slow-Release Cytokine Conjugates.
Introduction
John A. Hangasky III is an inventor associated with San Francisco, California. His work includes a patent for slow-release cytokine conjugates, an innovation related to controlled delivery of cytokines.
Latest Patents
Hangasky is listed as an inventor on 1 patent: “Slow-Release Cytokine Conjugates.” The patent concerns conjugates designed to provide the gradual release of cytokines.
Career Highlights
Hangasky is associated with ProLynx LLC, a company connected to the development of the patented technology. The available information identifies his contribution through the slow-release cytokine conjugate invention.
Collaborations
The patent lists Samuel J. Pfaff and Daniel V. Santi as fellow inventors, reflecting their collaboration on the cytokine-conjugate technology.
Conclusion
John A. Hangasky III’s patent work centers on slow-release cytokine conjugates and represents a collaborative contribution to innovation in controlled cytokine delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile